- Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats
-
Hussien NI, Ebrahim N, Mohammed O, Sabry D
- KMID: 2400867
- Int J Stem Cells.
- 2017 Nov;10(2):129-143.
- doi: 10.15283/ijsc17035
One of the new promising therapies in treatment of diabetes mellitus is mesenchymal stem cells (MSCs) which have an interesting therapeutic potentiality based on their paracrine effect and transdifferentiation potentiality.... -
- CITED
-
- Close
- SHARE
-
- Close
